Therapeutic observation of acupuncture plus turtle-shell-partitioned moxibustion for diarrhea-predominant irritable bowel syndrome

被引:0
作者
Pang G.-S. [1 ]
Chen Z.-L. [1 ]
机构
[1] Nanjing Qinhuai District Hospital of Chinese Medicine, Nanjing
关键词
Acupuncture Therapy; Acupuncture-moxibustion Therapy; Diarrhea; Indirect Moxibustion; Irritable Bowel Syndrome; Moxibustion Therapy;
D O I
10.1007/s11726-016-0895-5
中图分类号
学科分类号
摘要
Objective: To observe the clinical efficacy of acupuncture plus turtle-shell-partitioned moxibustion in treating diarrheapredominant irritable bowel syndrome (IBS-D). Methods: Seventy-six patients were randomized into two groups: 39 cases in the observation group were intervened by acupuncture plus turtle-shell-partitioned moxibustion, while 37 cases in the control group by the same acupuncture treatment, once a day, 10 d as a treatment course, for 2 courses in total. The improvements of symptoms were observed at the end of the intervention in both groups. Results: The total effective rate was 89.7% in the observation group versus 67.6% in the control group, and the difference was statistically significant (P<0.05). Conclusion: Acupuncture plus turtle-shell-partitioned moxibustion can significantly improve the symptoms of IBS-D, and can produce a more significant efficacy than acupuncture alone. © 2016, Shanghai Research Institute of Acupuncture and Meridian and Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:22 / 25
页数:3
相关论文
共 50 条
[41]   EFFECTS OF A PROPRIETARY BACILLUS COAGULANS PREPARATION ON SYMPTOMS OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME [J].
Dolin, B. J. .
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2009, 31 (10) :655-659
[42]   Neuroplasticity of the white matter tracts underlying recovery of diarrhea-predominant irritable bowel syndrome following acupuncture treatment [J].
Li, Jing ;
Ng, WingYi ;
Liu, YongKang ;
Fang, XiaoKun ;
Wang, ZhongQiu ;
Pei, LiXia ;
Wei, XueHu .
FRONTIERS IN NEUROSCIENCE, 2024, 18
[43]   Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective [J].
Lewis, James H. .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (01) :13-29
[44]   Influence of probiotic administration on the fecal microbiota in diarrhea-predominant irritable bowel syndrome [J].
C. Subramanyam ;
Nitesh Pratap ;
Prasad Gandham ;
Rupjyothi Talukdar ;
M. Sasikala ;
H. V. V. Murthy ;
D. Nageshwar Reddy .
Indian Journal of Gastroenterology, 2015, 34 (3) :275-276
[45]   Dysregulation of GABAergic Signalling Contributes in the Pathogenesis of Diarrhea-predominant Irritable Bowel Syndrome [J].
Aggarwal, Surbhi ;
Ahuja, Vineet ;
Paul, Jaishree .
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 24 (03) :422-430
[46]   Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome [J].
Chang, Full-Young ;
Lu, Ching-Liang ;
Chen, Chih-Yen ;
Luo, Jiing-Chyuan .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (12) :2266-2272
[47]   Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review [J].
Mangel, Allen W. ;
Hicks, Gareth A. .
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 :1-10
[48]   Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes [J].
Bleser, Scott .
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (03) :503-512
[49]   Current and emerging pharmacological approaches for treating diarrhea-predominant irritable bowel syndrome [J].
Munjal, Akhil ;
Dedania, Bhavtosh ;
Cash, Brooks D. .
EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (01) :63-71
[50]   Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome [J].
Katsumata, Ryo ;
Shiotani, Akiko ;
Murao, Takahisa ;
Ishii, Manabu ;
Fujita, Minoru ;
Matsumoto, Hiroshi ;
Haruma, Ken .
INTERNAL MEDICINE, 2017, 56 (09) :993-999